The Center for Vaccine Development and Global Health is dedicated to improving global health by conducting innovative, world-leading research in Baltimore and around the world. Center for Vaccine Development and Global Health (CVD), is directed by Kathleen Neuzil, MD, MPH. CVD is a leader in 40-year mission to develop, test and deploy vaccines against infectious diseases that will aid the world's underserved population. Our Malaria Research Program under the leadership of Miriam Laufer, MD, MPH, performs the crucial work needed to support global malaria eradication. That work includes developing and deploying innovative tools for improved malaria treatment, prevention and surveillance. With nearly 40 faculty physicians and scientists, the CVD collaborates with other University of Maryland School of Medicine institutes, centers, departments and programs, as well as other schools on campus, and other entities within the University System of Maryland.
External link for Center for Vaccine Development & Global Health
685 West Baltimore Street
Baltimore, MD 21201, US
Congrats to Neuzil Kathy for her leadership. #globalhealth
👏Join us in congratulating Dr. Kathleen Neuzil on her official swearing-in as Director of the Fogarty International Center at The National Institutes of Health! 🎉 With over 7 months already under her belt, Dr. Neuzil has brought a wealth of experience to the center, as an infectious disease and vaccine expert, and advocate for health equity here in the U.S. and around the globe. 🌎
Center for Vaccine Development & Global Health reposted this
We are hiring! If you three years of have media relations/marketing experience with comfort using graphic design software, we'd love to hear from you. Our Center for Vaccine Development and Global Health is a great place to work with incredible benefits. You'll also be part of the UM School of Medicine's media relations team. https://lnkd.in/edhAQPJG
Center for Vaccine Development & Global Health reposted this
Director of Malaria Research Program and Associate Dean for Student Research and Education at University of Maryland School of Medicine
Let the impact begin. Center for Vaccine Development & Global Health University of Maryland School of Medicine making the world healthier every day. Sharing some of our successes American Society of Tropical Medicine and Hygiene (ASTMH) annual meeting #TropMed24 Nginache Nampota-Nkomba Osward Nyirenda Matt Laurens
Medical doctor | Vaccine and Drug Development Scientist | Epidemiologist | Clinical Researcher | PhD Student
On day 2 at American Society of Tropical Medicine and Hygiene (ASTMH) I got to share our data on one and two dose, as well as booster dose typhoid conjugate vaccine immunogenicity from Malawi. It was a great discussion. #TakeOnTyphoid #TropMed24 #Vaccineswork Osward Nyirenda Priyanka Patel Terrie Taylor
A new study by UMD and UMSOM researchers explores a novel malaria vaccine using machine learning and "reverse vaccinology." The team identified promising vaccine targets to combat drug-resistant malaria. Learn more about their innovative approach and its potential impact on global health! https://lnkd.in/ehCFBNmB
University of Maryland School of Medicine Launches Vaccine Development Program to Prevent Sepsis in Newborns https://lnkd.in/eNbvfTR2
Center for Vaccine Development & Global Health reposted this
CARB-X will award US$3.96 million to the Center for Vaccine Development & Global Health (CVD) at the University of Maryland School of Medicine to develop a maternal vaccine that prevents sepsis caused by Klebsiella pneumoniae in newborns and infants. The CVD vaccine, which targets the surface sugars of K. pneumoniae, is expected to be given to pregnant women, thereby protecting their babies from this deadly infection. If successful, researchers expect the vaccine will prevent 80-90% of K. pneumoniae neonatal sepsis infections. The CARB-X award supports examining the feasibility of this project to reach a high potential impact for the vulnerable patient population. Neonatal sepsis is a life-threatening response to bloodstream infections that occur in newborns fewer than 28 days old. Due to their immature immune systems, newborns are particularly susceptible to infections. The BARNARDS study estimated that 2.5 million neonates or infants in the first month of life die annually of sepsis, with the greatest burden in low- and middle-income countries. Since neonatal sepsis progresses rapidly, it requires immediate treatment with IV fluids and antibiotics. The risk of death from neonatal sepsis increases 7.6% every hour a treatment is delayed. 🔗 Read more: bit.ly/3ysebI9 #AMR #StopSuperBugs #SuperBugs #AntibioticResistance #Medicine #GlobalHealth #ProductDevelopment #Innovation #Biotechnology #LMICs #antibiotics #NeonatalSepsis Boston University School of Law Boston University Biomedical Advanced Research and Development Authority (BARDA) HHS Administration for Strategic Preparedness and Response National Institute of Allergy and Infectious Diseases (NIAID) Wellcome Trust Department of Health and Social Care UK Health Security Agency Bundesministerium für Bildung und Forschung Bill & Melinda Gates Foundation Government of Canada Novo Nordisk Foundation Centre for Cellular and Molecular Platforms (C-CAMP) FIND German Center for Infection Research Institute For Life Science Entrepreneurship (ILSE)
Vaccines have saved 150 million children over the last 50 years, preventing countless deaths from fatal diseases. Every ten seconds, one child is saved thanks to vaccines. Learn more about the impact of vaccines on child health at Our World in Data. https://lnkd.in/g8AJk9-t
We consider ourselves very lucky to have 2021 Sabin Rising Star winner Dr. Nampota-Nkomba working with us! Learn more as she discusses vaccine acceptance in Malawi, catching children up on immunizations, & building relationships with the community. https://lnkd.in/evRgWQVr
Are you passionate about vaccine research and immunology? CVD is looking for dedicated individuals to join Dr. Marcela Pasetti's laboratory. https://ow.ly/rKml50RxW3Z Laboratory Research Assistant - Jumpstart your career with hands-on experience in a leading vaccine development lab. Laboratory Research Specialist / Lead Specialist - Elevate your research skills, contribute and lead groundbreaking immunological studies. Why Join Us? Sign-On Bonus: A financial appreciation to welcome you to our team. World-Class Research: Engage in innovative development of vaccines against pathogens affecting children globally. Cutting-Edge Techniques: Master the latest in immunological assays and vaccine delivery systems.